Skip to main content
Caplight Logo









AVAVA

AVAVA

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://avavaskin.com/

Last Round

Early Stage

VC

Mar 4, 2026

Total Funding Raised

$80.61M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AVAVA is a medical aesthetics company that develops and commercializes image-guided, focused intradermal laser products for skin rejuvenation and the treatment of skin conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

medical aestheticslaser skin rejuvenationaesthetic laserlaser treatmentdermatology lasermedspa equipmentskin resurfacingaesthetic medicinecosmetic dermatologyenergy-based devicemelasma treatmenthyperpigmentation treatmentpractice management softwaremedical aesthetics softwareaesthetic practice management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AVAVA Comparables

Compare AVAVA with similar companies based on industry and business-model similarity.

AVAVA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Advalight
84%
Aerolase
80%
Cynosure
78%

AVAVA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 4, 2026
Series CJun 12, 2024
Series CJun 12, 2024
Series BApr 5, 2024
Series BMar 4, 2021
Series A
Jan 9, 2017

AVAVA Investors

Notable investors and investment history

AVAVA investors
InvestorRounds
Catalio Capital ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 56% month-over-month.

  • Jul 24, 2026

    Monthly visitors increased 87% MoM.

Recent news

Latest coverage and updates

  • receives_financingSep 17, 2026

    Avava, Inc. received financing of $30M in equity financing on Sep 17th '26.

  • receives_financingSep 17, 2026

    Avava, Inc. received financing of $45M in financing on Sep 17th '26.

AVAVA Filings

Explore SEC and related filing metadata, where available.

AVAVA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AVAVA's valuation, stock price, and market status.

Is AVAVA a public or private company?

AVAVA is a private company.

What is the current stock price of AVAVA?

AVAVA is a private company with no public stock price. No recent secondary market data is available.

How much is AVAVA worth (valuation)?

Valuation information for AVAVA is not publicly available.

Can I buy AVAVA stock?

AVAVA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AVAVA's last funding round?

AVAVA's most recent funding round was Early Stage VC on March 4, 2026.

Who are the main investors in AVAVA?

Key investors in AVAVA include Jeisys Medical, Catalio Capital Management.

Will AVAVA IPO soon?

No public IPO plans have been announced for AVAVA.

How can I track AVAVA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AVAVA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range68
Year Founded2016
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?